1-4 of 4
Sheila Diamond
Close
Sort by
Journal Articles

Phosphorus Disruption Is Associated with the Incidence and Severity of Neurotoxicity Symptoms in CD19-Targeted CAR-T Cell Therapy: A Pooled Clinical Trial Analysis

Penelope Lafeuille, Sheila Diamond, Alexandru Socolov, Jacob Aptekar, Theodore Nowicki
Journal: Blood
Blood (2023) 142 (Supplement 1): 3626.
https://doi.org/10.1182/blood-2023-182138
Published: 2023
Journal Articles

Machine Learning-Based Decision Tree for Identifying and Grading Severity of Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) Based on Neurological Adverse Events in Patients Treated with CD19 CAR-T

Alexandru Socolov, Penelope Lafeuille, Sheila Diamond, Eric Yang, Francesco Maura, Jacob Aptekar, Esther Nie
Journal: Blood
Blood (2023) 142 (Supplement 1): 5018.
https://doi.org/10.1182/blood-2023-182147
Published: 2023
Journal Articles

Immune Checkpoint Inhibitors and the Risk of Cardiovascular Adverse Events: A Pooled Clinical Trial Database Analysis

Kayleen Ports, Rahul Jain, Sheila Diamond, Jacob Aptekar, David C. Fajgenbaum
Journal: Blood
Blood (2023) 142 (Supplement 1): 6933.
https://doi.org/10.1182/blood-2023-181968
Published: 2023
Journal Articles

Quantitative Changes in Serum Proteins Including CXCL13 Are Early Indicators of Response to Anti-IL6 Therapy in Idiopathic Multicentric Castleman Disease

Sheila K Pierson, MS, Laura Katz, MA, Christopher Sheild Nabel, MD PhD, Jason R Ruth, PhD, Sheila Diamond, MS, CGC, Hrishikesh Karvir, PhD, Fanyi Zhang, MS, Manjula P Reddy, MS, MSc, Mary Guilfoyle, MS, Craig Tendler, MD, Frits van Rhee, MD PhD, Philip Beineke, MS, Ana B Oromendia, PhD, David C Fajgenbaum, MDMBA,MSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 3599.
https://doi.org/10.1182/blood-2019-128284
Published: 2019